Shares of IntriCon Co. (NASDAQ:IIN) have been assigned an average recommendation of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $54.00.
A number of research firms have issued reports on IIN. ValuEngine downgraded shares of Whiting USA Trust II from a “hold” rating to a “sell” rating in a research report on Tuesday, May 7th. Zacks Investment Research upgraded shares of Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a research report on Saturday.
NASDAQ:IIN traded down $0.32 during trading hours on Wednesday, reaching $20.30. 135,432 shares of the company’s stock were exchanged, compared to its average volume of 154,959. The stock has a market cap of $177.36 million, a P/E ratio of 31.72, a P/E/G ratio of 3.03 and a beta of 0.77. IntriCon has a 12 month low of $19.91 and a 12 month high of $76.80. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.13 and a quick ratio of 2.23. The stock has a 50-day moving average price of $23.66.
IntriCon (NASDAQ:IIN) last issued its earnings results on Monday, April 29th. The technology company reported $0.08 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.10 by ($0.02). The business had revenue of $30.11 million for the quarter, compared to the consensus estimate of $30.05 million. IntriCon had a return on equity of 7.39% and a net margin of 4.58%. On average, sell-side analysts forecast that IntriCon will post 0.58 EPS for the current year.
Institutional investors and hedge funds have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA bought a new position in IntriCon in the 1st quarter worth $40,000. Rhumbline Advisers raised its holdings in IntriCon by 58.9% in the 4th quarter. Rhumbline Advisers now owns 9,104 shares of the technology company’s stock worth $240,000 after acquiring an additional 3,375 shares during the period. Conestoga Capital Advisors LLC bought a new position in IntriCon in the 1st quarter worth $235,000. Paloma Partners Management Co bought a new position in IntriCon in the 4th quarter worth $264,000. Finally, Brasada Capital Management LP acquired a new stake in IntriCon in the 1st quarter worth $251,000. Hedge funds and other institutional investors own 72.51% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Read More: Retained Earnings
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.